Search results for "COPD"
New diabetes drug, LABA for COPD, skin antibiotic approved
This update covers approval of a sodium-glucose co-transporter 2 inhibitor for diabetes, a once-daily long-acting beta-adrenergic agonist (LABA) for chronic obstructive pulmonary disease (COPD), and a new intravenous drug for bacterial skin and skin-structure infections.
https://immattersacp.org/archives/2014/10/fda.htm
1 Oct 2014
Combination therapy for COPD associated with better outcomes
A combination of a long-acting beta-agonist (LABA) and inhaled corticosteroid (ICS) therapy was associated with a lower risk of death or hospitalization among older adults with chronic obstructive pulmonary disease (COPD), particularly those with asthma, compared with LABAs alone, a study found.
https://immattersacp.org/weekly/archives/2014/09/23/1.htm
23 Sep 2014
Target preop visits for efficiency, best outcomes
Internists can guide preoperative anticoagulation, ensure that patients are in optimal condition for procedures, and##mdash;perhaps most importantly##mdash;judiciously choose which tests to perform and which ones aren't needed.
https://immattersacp.org/archives/2014/09/preop.htm
1 Sep 2014
MKSAP Quiz: 1-year history of cough
A 38-year-old man is evaluated for a 1-year history of cough with mucoid sputum and a 6-month history of mildly progressive dyspnea. He has a 12-pack-year history of smoking. He has no history of asthma, allergies, skin disease, or liver disease. Following physical and pulmonary exams and lab studies, what is the most appropriate next step in management?
https://immattersacp.org/weekly/archives/2014/06/10/3.htm
10 Jun 2014
For effective smoking cessation, turn ambivalence into action
Smokers sometimes want to want to quit. The ambivalence is the effect of nicotine, which rewires the brain. Instead of being wary of the patient's mixed feelings, use them as a sign to try nicotine replacement therapy systems that make the cravings more manageable.
https://immattersacp.org/archives/2014/06/smoking.htm
1 Jun 2014
New drugs approved for type 2 diabetes and COPD
This regulatory update covers dapaglifozin (Farxiga) a sodium-glucose co-transporter 2 inhibitor, to treat diabetes, and umeclidinium and vilanterol inhalation (Anoro Ellipta) for maintenance of chronic obstructive pulmonary disease.
https://immattersacp.org/archives/2014/03/fda.htm
1 Mar 2014
Low-dose opioids may safely reduce breathlessness in severe COPD
Lower doses of opioids do not appear to increase hospital admissions or death in patients with very severe chronic obstructive pulmonary disease (COPD) and may safely reduce symptoms, according to a new study.
https://immattersacp.org/weekly/archives/2014/02/11/6.htm
11 Feb 2014
MKSAP Quiz: Recent onset of fatigue and muscle weakness
A 52-year-old man is evaluated for recent onset of fatigue and muscle weakness. The patient further reports nocturia and polyuria over the past 4 weeks and a 6-kg (13.2-lb) weight loss over the past 2 months. He has COPD and a 55-pack-year smoking history. His only medication is an albuterol inhaler. Temporal muscle wasting and proximal muscle wasting and weakness are noted in the upper and lower extremities on physical exam. Hyperpigmented mucous membranes are noted. Following laboratory studies and examination of the toenail beds, what is the most likely cause of this patient's findings?.
https://immattersacp.org/archives/2014/02/mksap.htm
1 Feb 2014
CME Bulletin BoardAccreditation:The American College of Physicians is accredit-ed ...
CME Bulletin BoardAccreditation:The American College of Physicians is accredit-ed by the Accreditation Council for ContinuingMedical Education to provide continuing medi -cal education for physicians.
https://immattersacp.org/archives/2014/02/acpi-201402-puzzle_t2.pdf
23 Jan 2014
Telemonitoring for COPD may not affect exacerbation readmissions, quality of life
Telemonitoring in chronic obstructive pulmonary disease (COPD) patients at high risk for exacerbations did not affect hospital readmissions or improve quality of life, according to a new study.
https://immattersacp.org/weekly/archives/2013/10/29/4.htm
29 Oct 2013